28.12.2013 Views

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

138<br />

Safety-Field Evidence of Safety<br />

2.4<br />

2.2<br />

2.0<br />

1.8<br />

1 1<br />

30 145<br />

1<br />

30<br />

/1<br />

i<br />

1<br />

i I<br />

I<br />

,tl<br />

t 20<br />

PERIOD OF VACCINATION<br />

NUMBER OF INDIVIDUALS VACCINATED<br />

1.6<br />

1.4<br />

1.2<br />

1.0<br />

.<br />

I<br />

0.8<br />

, 1<br />

0.6<br />

0.4<br />

0.2<br />

REGION<br />

I<br />

0.6<br />

0.4<br />

0.2<br />

REGION II<br />

1.2<br />

1.0<br />

0.8<br />

0.6<br />

0.4<br />

0.2<br />

REGION<br />

III<br />

1.0<br />

REGION<br />

IV<br />

- -. - a -1-<br />

1959<br />

REGION V<br />

FIG. 4. Morbidity per 100,000 of population of reported cases of poliomyelitis during 3-month periods.<br />

monkey kidney-cells in a medium consisting of<br />

Hanks' solution with 0.5 per cent lactalbumin<br />

hydrolysate, 5 per cent horse serum, and the<br />

usual antibiotics. Four of the monolayers were<br />

incubated at 37 ° C. and four at 40 ° C. The<br />

final reading was made at the eighth day and the<br />

titers were calculated according to the method<br />

of Reed and Muench. It was found in preliminary<br />

titrations that the difference in titer<br />

at both temperatures was usually less than two

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!